Delhi Neonatal Outbreak: Know About The Rare Pathogen Behind It

An outbreak of dangerous, rare yeast in a neonatal intensive care unit in Delhi has led to the rapid evolution of the pathogen, which is highly resistant to disinfectants commonly used in hospital rooms.

Delhi Neonatal Outbreak

The pathogen, known as Lodderomyces elongisporus, typically infects immunocompromised adult patients or intravenous drug users but has now begun to affect premature infants as well [1].

According to the study published in the journal mBio, patients with a yeast infection may be treated with antifungal medications; however, the yeast is remarkably resistant to the strong disinfectant bleach commonly used to sanitise hospitals.

Delhi Neonatal Outbreak: What We Know So Far

  • In the Delhi neonatal outbreak, clusters of infection occurred in the fall of 2021 and in early 2022. Despite repeated deep cleaning in the intensive care unit, the researchers said, ten infants became infected over a six-month period, and nine of them survived after receiving antifungal treatment.
Delhi Neonatal Outbreak
  • Scientists at the University of Delhi's VP Chest Institute collected samples from the infants and swabbed the neonatal intensive care unit. They discovered that the railing and temperature control panel of the open care warmer were infected with L. elongisporus, a type of fungus.
  • The pathogen can infect premature babies as well as immunocompromised adults. Yeasts such as this are among a growing number of fungi that can cause severe infections in humans.
  • Further study of the genetic mechanisms underlying their adaptation to humans, hospitals, and natural environments is required in order to prevent their spread and persistence.
  • The findings are concerning since the hospital environment appears to be promoting the growth of fungi that are highly resistant to stress. They are adapting and evolving at an extremely rapid rate.
Delhi Neonatal Outbreak

On A Final Note...

Researchers stated that if these pathogens are prevented from entering hospital environments where many immunocompromised people are present, then there is a much greater chance of controlling them.